Global Cardiopulmonary Assist System(ECMO) Market Growth 2025-2031

The global Cardiopulmonary Assist System(ECMO) market size is predicted to grow from US$ 322 million in 2025 to US$ 421 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.

ECMO is used for long-term extracorporeal respiratory and circulatory support for patients, replacing the functions of the patient"s own heart and lungs, completing oxygenation of blood outside the body and expelling carbon dioxide.

United States market for Cardiopulmonary Assist System(ECMO) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cardiopulmonary Assist System(ECMO) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cardiopulmonary Assist System(ECMO) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cardiopulmonary Assist System(ECMO) players cover Getinge, LivaNova, Medtronic, Terumo Cardiovascular, Fresenius, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Cardiopulmonary Assist System(ECMO) Industry Forecast” looks at past sales and reviews total world Cardiopulmonary Assist System(ECMO) sales in 2024, providing a comprehensive analysis by region and market sector of projected Cardiopulmonary Assist System(ECMO) sales for 2025 through 2031. With Cardiopulmonary Assist System(ECMO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiopulmonary Assist System(ECMO) industry.

This Insight Report provides a comprehensive analysis of the global Cardiopulmonary Assist System(ECMO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiopulmonary Assist System(ECMO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiopulmonary Assist System(ECMO) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiopulmonary Assist System(ECMO) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiopulmonary Assist System(ECMO).

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiopulmonary Assist System(ECMO) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
V-V-ECMO
V-A-ECM

Segmentation by Application:
Aldult
Newborn
Child

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Getinge
LivaNova
Medtronic
Terumo Cardiovascular
Fresenius
Shenzhen Hannuo Medical Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiopulmonary Assist System(ECMO) market?

What factors are driving Cardiopulmonary Assist System(ECMO) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiopulmonary Assist System(ECMO) market opportunities vary by end market size?

How does Cardiopulmonary Assist System(ECMO) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.